TrialClinical pharmacology and therapeutics2024

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

Shruti M Raja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.